Tempus AI Comprehensive Income 2025-2024 | TEM

Tempus AI comprehensive income from 2025 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Tempus AI comprehensive income for the quarter ending June 30, 2024 was $M, a NAN% increase year-over-year.
  • Tempus AI comprehensive income for 2023 was $0B, a NAN% decline from .
  • Tempus AI comprehensive income for was $0B, a NAN% decline from .
  • Tempus AI comprehensive income for was $0B, a NAN% decline from .
Tempus AI Annual Comprehensive Income
(Millions of US $)
2023 $
Tempus AI Quarterly Comprehensive Income
(Millions of US $)
2024-06-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $7.918B $0.000B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $40.428B 21.75
Inspire Medical Systems (INSP) United States $6.215B 1157.72
Axonics (AXNX) United States $3.513B 0.00
Hims & Hers Health (HIMS) United States $3.503B 203.88
10x Genomics (TXG) United States $2.660B 0.00
Enovis (ENOV) United States $2.437B 17.67
Azenta (AZTA) United States $2.413B 137.03
Privia Health (PRVA) United States $2.280B 158.92
IRhythm Technologies (IRTC) United States $2.219B 0.00
Omnicell (OMCL) United States $1.968B 64.82
Clover Health Investments (CLOV) United States $1.492B 0.00
Schrodinger (SDGR) United States $1.436B 0.00
Phreesia (PHR) United States $1.389B 0.00
Standard BioTools (LAB) United States $0.753B 0.00
Fulgent Genetics (FLGT) United States $0.694B 0.00
Definitive Healthcare (DH) United States $0.538B 456.00
Health Catalyst (HCAT) United States $0.529B 0.00
Butterfly Network (BFLY) United States $0.406B 0.00
Talkspace (TALK) United States $0.343B 0.00
Pulmonx (LUNG) United States $0.329B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.286B 0.00
TruBridge (TBRG) United States $0.183B 13.44
P3 Health Partners (PIII) United States $0.165B 0.00
American Well (AMWL) United States $0.147B 0.00
Augmedix (AUGX) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.090B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
SHL Telemedicine (SHLT) Israel $0.055B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
111 (YI) China $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
CareCloud (CCLD) United States $0.045B 0.00
Movano (MOVE) United States $0.036B 0.00
Outset Medical (OM) United States $0.034B 0.00
MSP Recovery (LIFW) United States $0.025B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Syra Health (SYRA) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00